Abstract
Background
The impact of lifestyle factors such as adiposity, smoking, stress, exercise, and nutrition on anti-Müllerian hormone (AMH) levels remains an unresolved question.
Aims
This study aims to examine the anthropometric and lifestyle characteristics of women undergoing infertility investigations and to examine the relationship between serum AMH levels and body fat percentage, body mass index (BMI), and lifestyle factors including smoking, alcohol intake, nutrition, exercise, and stress.
Methods
Only women undergoing infertility investigations were included in the study. Those with a diagnosis of polycystic ovary syndrome (PCOS) were excluded. Body fat percentage was measured using the Tanita Body Composition Monitor and BMI calculated. Lifestyle factors were evaluated using the Simple Lifestyle Indicator Questionnaire (SLIQ).
Results
Ninety-six women took part in the study. Of these, 35.4% (n = 34) were obese, and 28.1% (n = 27) were overweight according to their BMI. According to body fat percentage, 47.9% (n = 46) were classified as obese. An “unhealthy “ SLIQ score was measured in 25% (n = 24) of participating women. There was no relationship between AMH and anthropometric or lifestyle factors, namely, body fat percentage (B = − 0.11, p = 0.76), BMI (B = − 0.14, p = 0.76), smoking [currents smokers (B = − 1.86, p = 0.56), ex-smoker (B = 3.07, p = 0.41)], SLIQ score (B = 0.1.96, p = 0.29), stress (B = 0.12, p = 0.96), exercise (B = − 0.94, p = 0.77), alcohol (B = − 0.94, p = 0.77), or nutrition (B = − 3.14, p = 2.44).
Conclusions
Body fat percentage, BMI, lifestyle choices, and high stress levels do not correlate with AMH levels in women seeking infertility investigations. We identified a high incidence of obesity and low levels of healthy lifestyle scores in our study population. Our study highlights the urgent need for patient education and optimization of pre-pregnancy health.
Similar content being viewed by others
References
Shahrokhi S, Kazerouni F, Ghaffari F (2018) Anti-Müllerian hormone: Genetic and environmental effects. Clin Chim Acta 276:123–129
Simões-Pereira J et al (2018) Influence of body mass index in anti-Müllerian hormone levels in 951 non-polycystic ovarian syndrome women followed at a reproductive medicine unit. Endocrine 61(1)
Maciel G, Baracat E, Sá FMSD (2018) About the anti-Müllerian hormone (AMH) uses in the clinical practice. Rev Bras Ginecol Obstet 40(11):661–663
World Health Organization (WHO) (2020) Obesity and overweight. Fact Sheet. Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
Prentice A, Jebb SA (2001) Beyond body mass index. Obes Rev 2:141–147
Fattah C et al (2010) Maternal weight and body composition in the first trimester of pregnancy. Acta Obstet Gynecol Scand 89:952–955
Nuttall F (2015) Body mass index, obesity, BMI, and health: A critical review. Nutr Today 50:117–128
Anderson L, Erceg D, Schroeder E (2012) Utility of multifrequency bioelectrical impedance compared with dual-energy x-ray absorptiometry for assessment of total and regional body composition varies between men and women. Nutr Res 32:479–485
Ling C et al (2011) Accuracy of direct segmental multi-frequency bioimpedance analysis in the assessment of total body and segmental body composition in middle-aged adult population. Clin Nutr 30(5):610–615
Shafer K et al (2009) Validity of segmental multiple- frequency bioelectrical impedance analysis to estimate body composition of adults across a range of body mass indexes. Nutrition 25:25–32
Kyle U et al (2004) Bioelectrical impedance analysis–part I: review of principles and methods. Clin Nutr 23(5):1226–1243
Gorkem U et al (2019) Obesity does not compromise ovarian reserve markers in infertile women. Geburtshilfe Frauenheilkd 79:79–85
Lefebvre T et al (2017) Effect of obesity and its related metabolic factors on serum anti-Müllerian hormone concentrations in women with and without polycystic ovaries. Reprod Biomed Online 35(3):325–330
Kriseman M et al (2015) Antimullerian hormone levels are inversely associated with body mass index (BMI) in women with polycystic ovary syndrome. J Assist Reprod Genet 32(9):1313–1316
Sahmay S et al (2012) Is there any correlation between AMH and obesity in premenopausal women? Arch Gynecol Obstet 286(3):661–665
Nardo L et al (2007) Anti-Mullerian hormone levels and antral follicle count in women enrolled in in vitro fertilization cycles: relationship to lifestyle factors, chronological age and reproductive history. Gynecol Endocrinol 23(8):486–493
Rios J et al (2020) Associations between anti-Mullerian hormone and cardiometabolic health in reproductive age women are explained by body mass index. J Clin Endocrinol Metab 105(3)
Moslehi N et al (2018) Is ovarian reserve associated with body mass index and obesity in reproductive aged women? A meta-analysis. Menopause 25:1046–1055
Nouri M et al (2016) Association between BMI and gene expression of anti-Müllerian hormone and androgen receptor in human granulosa cells in women with and without polycystic ovary syndrome. Clin Endocrinol (Oxf) 85(4):590–595
Dunlevy F (2013) Nutrition in pregnancy, clinical practice guideline. Institute of Obstetricians and Gynaecologists, Royal College of Physicians of Ireland and Directorate of Clinical Strategy and Programmes, Health Service Executive 1–48
Moslehi N et al (2017) Current evidence on associations of nutritional factors with ovarian reserve and timing of menopause: A systematic review. Adv Nutr 8(4):597–612
Plante B et al (2010) The impact of smoking on antimüllerian hormone levels in women aged 38 to 50 years. Menopause 17(3):571–576
Hawkins Bressler L et al (2016) Alcohol, cigarette smoking, and ovarian reserve in reproductive-age African-American women. Am J Obstet Gynecol 215(6):758–758
Dafopoulos A et al (2010) Smoking and AMH levels in women with normal reproductive history. Arch Gynecol Obstet 282(2):215–219
Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod
Godwin M et al (2013) Concurrent and convergent validity of the simple lifestyle indicator questionnaire. 6
Godwin M et al (2008) Testing the Simple Lifestyle Indicator Questionnaire: Initial psychometric study. Can Fam Physician 54(1):76–77
World Health Organization (WHO) (2000) Obesity: Preventing and managing the global epidemic. Geneva: World Health Organization.
Hamdy O, Uwaifo GE (2020) Oral obesity. Endocrinology
Diagnostics R (2020) Elecsys AMH (anti-Mullerian hormone). Available from: https://diagnostics.roche.com/global/en/products/params/elecsys-amh-anti-mullerian-hormone.html#productInfo
Templeton G (2011) A two-step approach for transforming continuous variables to normal: Implications and recommendations for IS research. Commun Assoc Inf Syst 28. https://doi.org/10.17705/1CAIS.02804
Amanvermez R, Tosun M (2016) An update on ovarian aging and ovarian reserve tests. Int J Fertil Steril 9:411–415
Jamil Z et al (2016) Anti-Mullerian hormone: Above and beyond conventional ovarian reserve markers. Dis Markers 2016(5246217)
Best D, Bhattacharya S (2015) Obesity and fertility. Horm Mol Biol Clin Invest 24(1):5–10
Homan G, Davies M, Norman R (2007) The impact of lifestyle factors on reproductive performance in the general population and those undergoing infertility treatment: A review. Hum Reprod Update 13:209–223
Anderson K, Norman R, Middleton P (2010) Preconception lifestyle advice for people with subfertility. Cochrane Database Syst Rev 14
Sharma R et al (2013) Lifestyle factors and reproductive health: Taking control of your fertility. Reprod Biol Endocrinol 11
Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG) (2015) Pre pregnancy counselling. Available from: https://www.ranzcog.edu.au/Statements-Guidelines
The National Institute for Health and Care Excellence (NICE) (2021), Pre-conception- advice and management. Clinical Knowledge Summary. Available from: https://www.nice.org.uk/
King JC (2016) A summary of pathways or mechanisms linking preconception maternal nutrition with birth outcomes. J Nutr 146(7):1437S-1444S
Visser J et al (2012) Anti-Müllerian hormone: An ovarian reserve marker in primary ovarian insufficiency. Nat Rev Endocrinol 8:331–341
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethics approval and consent to participate
This study attained full ethical approval from the Institutional Research Ethics Committee. Informed written consent was obtained from all subject.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Highlights
AMH does not correlate with anthropometric or lifestyle factors including body fat percentage, body mass index, smoking, Simple Lifestyle Indicator Questionnaire score, stress, exercise, alcohol or nutrition. Low SLIQ scores and high BMI (body fat composition) levels suggest pre-fertility therapy optimization of general health is a priority for all service providers.
Appendix 1. Simple lifestyle indicator questionnaire
Appendix 1. Simple lifestyle indicator questionnaire
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Mitchell, J.M., Fee, N., Roopnarinesingh, R. et al. Investigating the relationship between body composition, lifestyle factors, and anti-Müllerian hormone serum levels in women undergoing infertility assessment. Ir J Med Sci 192, 1909–1915 (2023). https://doi.org/10.1007/s11845-022-03148-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11845-022-03148-x